Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Tetrylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA1 known ✓ | Q09470 | 1/20 | 0.89 |
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.80 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.80 |
| ▸ | ATM | Q13315 | 1/20 | 0.80 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.36 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL10982451 | 1.00 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL31598896 | 1.00 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5374892 | 1.00 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28722640 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL10982446 | 0.95 | KDM4E (0.90) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL28900277 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5374887 | 0.95 | KDM4E (0.90) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2328980 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL22664596 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL9833434 | 0.95 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118931398-B | Blue film adhesive tape for new energy automobile battery and preparation method thereof | 博益鑫成高分子材料股份有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118931398-A | Blue film adhesive tape for new energy automobile battery and preparation method thereof | 博益鑫成高分子材料股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118620528-A | UV (ultraviolet) delay curing adhesive and preparation method thereof | 浙江国能科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-103301888-A | Preparation method of catalyst carrier for hydrotreating pretreatment of wax oil | CHINA NAT OFFSHORE OIL CORP | 2013-09-18 | — | — | CN | claimed |
| CN-103285914-A | Preparation method for hydrogenation pretreatment catalyst containing silicon aluminum-phosphorus aluminum composite molecule sieve | CHINA NAT OFFSHORE OIL CORP | 2013-09-11 | — | — | CN | claimed |
| US-20250186600-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2025-06-12 | — | — | US | disclosed |
| CN-119774625-A | Silica sol without secondary small particles and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-118931398-B | Blue film adhesive tape for new energy automobile battery and preparation method thereof | 博益鑫成高分子材料股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-118931398-A | Blue film adhesive tape for new energy automobile battery and preparation method thereof | 博益鑫成高分子材料股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118620528-A | UV (ultraviolet) delay curing adhesive and preparation method thereof | 浙江国能科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-20230270864-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2023-08-31 | — | — | US | disclosed |
| US-20220401559-A1 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | COMERA LIFE SCIENCES, INC. | 2022-12-22 | — | — | US | disclosed |
| US-20050069811-A1 | Actinic radiation absorber, polymerization initiator and a polymerzation monomer to form polymer layer that will carry ink that can be removed and forming images with exposure to laser beams | FUJIFILM CORPORATION (JP) | 2005-03-31 | — | — | US | disclosed |
| EP-1518672-A2 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-03-30 | — | — | EP | disclosed |
| CN-1387536-A | T2R, a novel class of taste receptors | UNIV CALIFORNIA (US) | 2002-12-25 | — | — | CN | disclosed |
| EP-0912184-B1 | USE OF K-252A DERIVATIVE FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVE DISORDERS, AND CYTOKINE OVERPRODUCTION | CEPHALON INC (US) | 2002-09-25 | — | — | EP | disclosed |
| US-6184217-B1 | ADMINISTERING ANTIINFLAMMATORY DOSAGE OF A RING-SUBSTITUTED INDOLOCARBAZOLE DERIVATIVE COMPOUND; TUMOR NECROSIS FACTOR (TNF) INHIBITORS | CEPHALON, INC. | 2001-02-06 | — | — | US | disclosed |
| EP-0912184-A1 | USE OF K-252A DERIVATIVE FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVE DISORDERS, AND CYTOKINE OVERPRODUCTION | CEPHALON, INC. (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1997049406-A1 | USE OF K-252A DERIVATIVE FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVE DISORDERS, AND CYTOKINE OVERPRODUCTION | CEPHALON, INC. (US) | 1997-12-31 | — | — | WO | disclosed |
| US-4324685-A | WATER SOLUBLE AMINE CHLORIDE | BECKMAN INSTRUMENTS, INC. (US) | 1982-04-13 | — | — | US | disclosed |